CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea
· Delayed Price · Currency is KRW 9,850.00
+80.00 (0.82%)
At close: Jul 11, 2025, 3:30 PM KST
CJ Bioscience Revenue
CJ Bioscience had revenue of 912.84M KRW in the quarter ending March 31, 2025, a decrease of -9.11%. This brings the company's revenue in the last twelve months to 3.38B, down -37.68% year-over-year. In the year 2024, CJ Bioscience had annual revenue of 3.47B, down -37.82%.
Revenue (ttm)
3.38B
Revenue Growth
-37.68%
P/S Ratio
38.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
128.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.47B | -2.11B | -37.82% |
| Dec 31, 2023 | 5.58B | 1.50B | 36.82% |
| Dec 31, 2022 | 4.07B | -288.37M | -6.61% |
| Dec 31, 2021 | 4.36B | -948.52M | -17.86% |
| Dec 31, 2020 | 5.31B | 528.32M | 11.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| KB Financial Group | 14.93T |
| Celltrion | 3,662.23B |
| Kia Corporation | 109.25T |